Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

Part of paid clinical trials in Tampa, Florida.

Sponsor
Sensorion
Study ID
NCT06354010
Status
Recruiting
Apply to this trial

Conditions

  • Sensorineural Hearing Loss, Bilateral

Eligibility Criteria

Sex
ALL
Age
30 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

  • Genotyping — GENETIC
    Genotyping to determine if patients present mutations to the gene GJB2.
  • Audiological assessments — OTHER
    Audiological assessments

Study Details

The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.

Key Dates

Start date
Jun 14, 2024
Status verified
May 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Patients with adulthood-onset bilateral sensorineural hearing loss (SNHL)
  • Arm: Patients that carry mutations in the gene GJB2 from patients with adulthood-onset bilateral SNHL

Primary Outcome Measure

Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene. [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of South Florida Board of TrusteesTampaFlorida33620
Victoria Sanchez, MD

Find similar trials in Tampa, FL

By research site
The University of South Florida Board of Trustees· Tampa, FL

Related Studies